These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24671224)

  • 21. [Expression and relationship of p27(kip1) and its nuclear export factor Jab1 in lymphoma cell Jurkat].
    Wang YC; Zhao YM; Shen AG; Lu JX; Zhang DM; He S; Cheng C
    Zhonghua Xue Ye Xue Za Zhi; 2007 Dec; 28(12):813-7. PubMed ID: 18476592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CACYBP Enhances Cytoplasmic Retention of P27
    Lian YF; Huang YL; Zhang YJ; Chen DM; Wang JL; Wei H; Bi YH; Jiang ZW; Li P; Chen MS; Huang YH
    Theranostics; 2019; 9(26):8392-8408. PubMed ID: 31754404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CKS1B overexpression implicates clinical aggressiveness of hepatocellular carcinomas but not p27(Kip1) protein turnover: an independent prognosticator with potential p27 (Kip1)-independent oncogenic attributes?
    Huang CW; Lin CY; Huang HY; Liu HW; Chen YJ; Shih DF; Chen HY; Juan CC; Ker CG; Huang CY; Li CF; Shiue YL
    Ann Surg Oncol; 2010 Mar; 17(3):907-22. PubMed ID: 19866239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. JAB1 expression is associated with inverse expression of p27(kip1) in hepatocellular carcinoma.
    Qin J; Wang Z; Wang Y; Ma L; Ni Q; Ke J
    Hepatogastroenterology; 2010; 57(99-100):547-53. PubMed ID: 20698225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gfer inhibits Jab1-mediated degradation of p27kip1 to restrict proliferation of hematopoietic stem cells.
    Teng EC; Todd LR; Ribar TJ; Lento W; Dimascio L; Means AR; Sankar U
    Mol Biol Cell; 2011 Apr; 22(8):1312-20. PubMed ID: 21346186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of p27 and Jun activation domain-binding protein 1 in endometriosis.
    Kim TH; Lee HH; Chung SH; Park J; Lee A
    Arch Gynecol Obstet; 2015 Aug; 292(2):377-81. PubMed ID: 25666480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased expression and prognostic role of cytoplasmic BRSK1 in human breast carcinoma: correlation with Jab1 stability and PI3K/Akt pathway.
    Wang H; Liu XB; Chen JH; Wang QQ; Chen JP; Xu JF; Sheng CY; Ni QC
    Exp Mol Pathol; 2014 Oct; 97(2):191-201. PubMed ID: 25036402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Jab1 Silencing Inhibits Proliferation and Sensitizes to Cisplatin in Biliary Tract Cancer.
    Nam AR; Kim JW; Park JE; Bang JH; Jin MH; Oh DY; Bang YJ
    Cancer Res Treat; 2019 Jul; 51(3):886-900. PubMed ID: 30282449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inhibitory effect of arsenic trioxide on proliferation of human hepatocellular carcinoma cell line SMMC-7721 and the mechanism].
    Cui XP; Wang Y; Lu MD; Li P; Shen AG
    Ai Zheng; 2007 Dec; 26(12):1304-8. PubMed ID: 18076791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Jab1/CSN5 negatively regulates p27 and plays a role in the pathogenesis of nasopharyngeal carcinoma.
    Pan Y; Zhang Q; Tian L; Wang X; Fan X; Zhang H; Claret FX; Yang H
    Cancer Res; 2012 Apr; 72(7):1890-900. PubMed ID: 22350412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression and significance of c-jun-activation-domain binding protein (JAB1) in hepatocellular carcinoma].
    Qin J; Wang ZW; Ni QC; Wang Y; Chen L; Lu MD; Shen AG
    Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(36):2533-6. PubMed ID: 19080643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1).
    Kouvaraki MA; Rassidakis GZ; Tian L; Kumar R; Kittas C; Claret FX
    Cancer Res; 2003 Jun; 63(11):2977-81. PubMed ID: 12782606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Jun activation domain binding protein 1 is overexpressed from the very early stages of hepatocarcinogenesis.
    Yachida S; Imaida K; Yokohira M; Hashimoto N; Suzuki S; Okano K; Wakabayashi H; Maeta H; Suzuki Y
    Ann Surg Oncol; 2010 Dec; 17(12):3386-93. PubMed ID: 20589433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression and significance of c-Jun activation domain binding protein 1 in human colorectal carcinoma].
    Guo Z; Lü Q; Zhang Y; Wang Z; Wen X; Yao M; Wu W
    Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(12):899-902. PubMed ID: 24854908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex.
    Tomoda K; Kubota Y; Arata Y; Mori S; Maeda M; Tanaka T; Yoshida M; Yoneda-Kato N; Kato JY
    J Biol Chem; 2002 Jan; 277(3):2302-10. PubMed ID: 11704659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. S100A14 promotes the growth and metastasis of hepatocellular carcinoma.
    Zhao FT; Jia ZS; Yang Q; Song L; Jiang XJ
    Asian Pac J Cancer Prev; 2013; 14(6):3831-6. PubMed ID: 23886191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Down-regulation of the cyclin-dependent kinase inhibitor p57 is mediated by Jab1/Csn5 in hepatocarcinogenesis.
    Guo H; Jing L; Cheng Y; Atsaves V; Lv Y; Wu T; Su R; Zhang Y; Zhang R; Liu W; Rassidakis GZ; Wei Y; Nan K; Claret FX
    Hepatology; 2016 Mar; 63(3):898-913. PubMed ID: 26606000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of cell cycle inhibitor p27Kip1 and its inactivator Jab1 in melanocytic lesions.
    Ivan D; Diwan AH; Esteva FJ; Prieto VG
    Mod Pathol; 2004 Jul; 17(7):811-8. PubMed ID: 15154004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Jun activation domain binding protein 1 expression is associated with low p27(Kip1)levels in node-negative breast cancer.
    Esteva FJ; Sahin AA; Rassidakis GZ; Yuan LX; Smith TL; Yang Y; Gilcrease MZ; Cristofanilli M; Nahta R; Pusztai L; Claret FX
    Clin Cancer Res; 2003 Nov; 9(15):5652-9. PubMed ID: 14654548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.
    Lei X; Li YF; Chen GD; Ou DP; Qiu XX; Zuo CH; Yang LY
    Oncotarget; 2015 Dec; 6(38):40622-41. PubMed ID: 26536663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.